Jiangsu Sihuan Bioengineering Co., Ltd (SHE:000518)
2.740
+0.020 (0.74%)
Jan 23, 2026, 3:04 PM CST
Jiangsu Sihuan Bioengineering Company Description
Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China.
It offers delusheng and xindelusheng, an anti-tumor biotherapeutic drug for the treatment of kidney cancer, malignant melanoma, and cancerous chest and abdominal mass.
It also engages in breeding and sales of flowers and seedlings; and landscaping projects. Jiangsu Sihuan Bioengineering Co., Ltd. was founded in 1992 and is headquartered in Jiangyin, China.
Jiangsu Sihuan Bioengineering Co., Ltd
| Country | China |
| Founded | 1992 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 277 |
| CEO | Yu Guo |
Contact Details
Address: No. 6 Zhongfang Jiangyin, 214426 China | |
| Phone | 86 510 8640 8558 |
| Website | 000518shsw.com |
Stock Details
| Ticker Symbol | 000518 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE0000001P8 |
| SIC Code | 2200 |
Key Executives
| Name | Position |
|---|---|
| Yu Guo | GM, Chairman and Secretary of the Board |
| Jie Zhao | Head of Accounting and Financial Director |